• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Recognition of influenza H3N2 variant virus by human neutralizing antibodies

tetano

Editor, Senior Moderator
JCI Insight. 2016 Jul 7;1(10). pii: e86673.
[h=1]Recognition of influenza H3N2 variant virus by human neutralizing antibodies.[/h] Bangaru S[SUP]1[/SUP], Nieusma T[SUP]2[/SUP], Kose N[SUP]3[/SUP], Thornburg NJ[SUP]4[/SUP], Finn JA[SUP]1[/SUP], Kaplan BS[SUP]5[/SUP], King HG[SUP]3[/SUP], Singh V[SUP]3[/SUP], Lampley RM[SUP]3[/SUP], Sapparapu G[SUP]4[/SUP], Cisneros A 3rd[SUP]6[/SUP], Edwards KM[SUP]7[/SUP], Slaughter JC[SUP]8[/SUP], Edupuganti S[SUP]9[/SUP], Lai L[SUP]9[/SUP], Richt JA[SUP]10[/SUP], Webby RJ[SUP]5[/SUP], Ward AB[SUP]2[/SUP], Crowe JE Jr[SUP]11[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Since 2011, over 300 human cases of infection, especially in exposed children, with the influenza A H3N2 variant (H3N2v) virus that circulates in swine in the US have been reported. The structural and genetic basis for the lack of protection against H3N2v induced by vaccines containing seasonal H3N2 antigens is poorly understood. We isolated 17 human monoclonal antibodies (mAbs) that neutralized H3N2v virus from subjects experimentally immunized with an H3N2v candidate vaccine. Six mAbs exhibited very potent neutralizing activity (IC[SUB]50[/SUB] < 200 ng/ml) against the H3N2v virus but not against current human H3N2 circulating strains. Fine epitope mapping and structural characterization of antigen-antibody complexes revealed that H3N2v specificity was attributable to amino acid polymorphisms in the 150-loop and the 190-helix antigenic sites on the hemagglutinin protein. H3N2v-specific antibodies also neutralized human H3N2 influenza strains naturally circulating between 1995 and 2005. These results reveal a high level of antigenic relatedness between the swine H3N2v virus and previously circulating human strains, consistent with the fact that early human H3 seasonal strains entered the porcine population in the 1990s and reentered the human population, where they had not been circulating, as H3N2v about a decade later. The data also explain the increased susceptibility to H3N2v viruses in young children, who lack prior exposure to human seasonal strains from the 1990s.


PMID: 27482543 PMCID: PMC4962875 DOI: 10.1172/jci.insight.86673
[PubMed] Free PMC Article
 
Back
Top Bottom